These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 10364775)

  • 1. Outpatient management of venous thromboembolism.
    Vanscoy GJ
    J Thromb Thrombolysis; 1999 Apr; 7(2):109-12. PubMed ID: 10364775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deep venous thrombosis and pulmonary embolism. Part 1. Initial treatment: usually a low-molecular-weight heparin.
    Prescrire Int; 2013 Apr; 22(137):99-101, 103-4. PubMed ID: 23662321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deep venous thrombosis: early discharge strategies and outpatient management.
    Baron RM; Goldhaber SZ
    J Thromb Thrombolysis; 1999 Apr; 7(2):113-22. PubMed ID: 10364776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unfractionated heparin and low-molecular-weight heparin for the initial treatment of acute venous thromboembolism.
    Prandoni P
    Haemostasis; 1998; 28 Suppl 3():85-90. PubMed ID: 10069766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tinzaparin in the treatment of venous thromboembolism.
    Pineo GF; Hull RD
    Expert Opin Pharmacother; 2003 Dec; 4(12):2355-62. PubMed ID: 14640933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outpatient treatment of acute venous thromboembolic disease.
    Yusen RD; Gage BF
    Clin Chest Med; 2003 Mar; 24(1):49-61. PubMed ID: 12685056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial comparing 2 low-molecular-weight heparins for the outpatient treatment of deep vein thrombosis and pulmonary embolism.
    Wells PS; Anderson DR; Rodger MA; Forgie MA; Florack P; Touchie D; Morrow B; Gray L; O'Rourke K; Wells G; Kovacs J; Kovacs MJ
    Arch Intern Med; 2005 Apr; 165(7):733-8. PubMed ID: 15824291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic therapy for the management of thrombosis: unfractionated heparin or low-molecular-weight heparin?
    Spyropoulos AC
    Clin Cornerstone; 2005; 7(4):39-48. PubMed ID: 16758651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anticoagulation in patients with venous thromboembolism].
    Rüfer A; Wuillemin WA
    Ther Umsch; 2003 Jan; 60(1):43-7. PubMed ID: 12638478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism.
    van Dongen CJ; van den Belt AG; Prins MH; Lensing AW
    Cochrane Database Syst Rev; 2004 Oct; (4):CD001100. PubMed ID: 15495007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outpatient treatment of venous thromboembolism using low molecular weight heparins. An overview.
    Matsagas MI
    Int Angiol; 2004 Dec; 23(4):305-16. PubMed ID: 15767978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evidence-based guidelines for prevention and therapy of venous thromboembolism].
    Falciani M; Dilaghi B; Conti AA; Caciolli S; Gensini GF
    Minerva Cardioangiol; 2000 Dec; 48(12 Suppl 1):27-35. PubMed ID: 11253337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low molecular weight heparins in the outpatient management of venous thromboembolism.
    Bick RL
    Semin Thromb Hemost; 1999; 25 Suppl 3():97-9. PubMed ID: 10549723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hospitalizations and Other Health Care Resource Utilization Among Patients with Deep Vein Thrombosis Treated with Rivaroxaban Versus Low-molecular-weight Heparin and Warfarin in the Outpatient Setting.
    Deitelzweig S; Laliberté F; Crivera C; Germain G; Bookhart BK; Olson WH; Schein J; Lefebvre P
    Clin Ther; 2016 Aug; 38(8):1803-1816.e3. PubMed ID: 27491278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism.
    Erkens PM; Prins MH
    Cochrane Database Syst Rev; 2010 Sep; (9):CD001100. PubMed ID: 20824828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tinzaparin in outpatients with pulmonary embolism or deep vein thrombosis.
    Dager WE; King JH; Branch JM; Chow SL; Ferrer RE; Pak S; Togioka PY; White RH
    Ann Pharmacother; 2005; 39(7-8):1182-7. PubMed ID: 15956232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low molecular weight heparins: the optimal treatment for venous thromboembolism.
    Daskalopoulos ME; Daskalopoulou SS; Liapis CD
    Curr Med Res Opin; 2004 Jul; 20(7):1001-5. PubMed ID: 15265244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of low-molecular-weight heparin and unfractionated heparin in treatment of deep vein thrombosis.
    Rodger M; Bredeson C; Wells PS; Beck J; Kearns B; Huebsch LB
    CMAJ; 1998 Oct; 159(8):931-8. PubMed ID: 9834718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A cost-effectiveness analysis.
    Gould MK; Dembitzer AD; Sanders GD; Garber AM
    Ann Intern Med; 1999 May; 130(10):789-99. PubMed ID: 10366368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venous thromboembolism and anticoagulant therapy in pregnancy.
    Greer IA
    Gend Med; 2005; 2 Suppl A():S10-7. PubMed ID: 16551552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.